Emerging carbapenem resistance among nosocomial isolates of Klebsiella pneumoniae in South India

International Journal of Pharma and Bio Sciences

Volumn 1, Issue 2, 2010, Pages

  Mohamudha Parveen, R ^a   Harish, B N ^a   Parija, S C ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Carbapenems; Klebsiella pneumoniae; KPC; Multidrug resistance; RAPD typing

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULPERAZON; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; INDIA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MODIFIED HODGE TEST; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PREVALENCE; TERTIARY HEALTH CARE;

EID: 84455168789     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Carpenter JL, Klebsiella pulmonary infections: occurrence at one medical center, Rev Infec Dis, 12 (4): 672-682, (1990).
2. Jacoby GA and Han P, Detection of extendedspectrum β -lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli, J Clin Microbiol, 34 (4):908-11, (1996).
3. Livermore DM, β -lactamase mediated resistance and opportunities for its control, J Antimicrob Chemother, 41(6): 25-41, (1998).
4. Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, and Von Gottberg A, Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β -lactamase production in Klebsiella pneumoniae isolates causing bacteremia, Clin Infect Dis, 30 (3): 473-478, (2000).
5. Gold HS and Moellering RC, Drug therapy: Antimicrobial-drug resistance, N Engl J Med, 335:1445-1452, (1996).
6. Hellinger, Walter C, Brewer, Nelson S, Carbapenems and monobactams: Imipenem, meropenem, and aztreonam, Mayo Clinic Proc, 74:420-34, (1999).
7. Rodloff AC, Goldstein EJ and Torres A, Two decades of imipenem therapy, J Antimicrob Chemother, 58 (5):916-29, (2006).
8. Matsumoto T, Kumazawa J and Nagayama, A sensitivities to four carbapenems of bacteria isolated from patients with refractory complicated urinary tract infections and the detection of carbapenemase-producing Pseudomonas aeruginosa, J Antimicrob Chemother, 38 (2):322-4, (1996).
9. Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E and Hoban DJ, Comparative review of the carbapenems, Drug, 67 (7):1027-52, (2007).
10. th Edn, Mosby publisher: London, (1998).
11. Bauer AW, Kirby WM, Sherris JC and Turek M, Antibiotic susceptibility testing by a standard single disc method, Am J Clin Pathol, 45 (4); 493-6, (1966).
12. CLSI. Performance standards for antimicrobial susceptibility testing for bacteria that grow aerobically, Approved standard M100-S17, Clinical and Laboratory Standards Institute, Seventeenth Informational supplement, Wayne, Pennsylvania, USA: 27-42, (2007).
13. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6 document, National committee for Clinical Laboratory Standards, Sixth Informational supplement, Wayne, Pennsylvania, USA, (2003).
14. Lee K, Chong Y, Shin HB, Kim YA, Yong D and Yum JH, Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamaseproducing strains of Pseudomonas and Acinetobacter species, Clin Microbiol Infect, 7 (2); 88-91, (2001).
15. Black JA, Moland ES and Thomson KS, AmpC Disk Test for Detection of Plasmid-Mediated AmpC β -Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC β -Lactamases, J Clin Microbiol, 43 (7); 3110-3113, (2005).
16. Tribuddharat C, Srifuengfung S and Chiangjong W, Preliminary Study of Randomly-Amplified Polymorphic DNA Analysis for Typing Extended-Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella pneumoniae, J Med Assoc Thai, 91 (4); 527-32, (2008).
17. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK and Kapil A, Emerging resistance to carbapenems in a tertiary care hospital in north India, Indian J Med Res, 124 (1): 95-98, (2006).
18. Prakash S, Carbapenem sensitivity profile amongst bacterial isolates from clinical specimens in Kanpur city, Indian J crit care med, 10 (4); 250-253, (2006).
19. Harish BN, Menezes GA, Shekatkar S and Parija SC, Extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae from blood culture, J Med Microbiol, 56:999-1000, (2007).
20. Rahal JJ, Urba C, Horn D, Freeman K, Segal-Maurer S and Maurer J, Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella, JAMA, 280 (14):1233-1237, (1998)
21. Meyer KS, Urban C, Eagan JA, Berger BJ and Rahal JJ, Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins, Ann Intern Med, 119 (5):353-358, (1993).
22. Kallel H, Bahloul M, Hergafi L, Akrout M, Ketata W and Chelly H, Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU, Int J Antimicrob Agents, 28 (4):366-369, (2006).
23. Antoniadou A, Kontopidou F, Poulakou G, Koratzanis E, Galani I and Papadomichelakis E, Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster, J Antimicrob Chemother, 59 (4):786-790, (2007).
24. Lucet JC, Decre D, Fichelle A, Joly-Guillou ML, Pernet M and Deblangy C, Control of a prolonged outbreak of extended-spectrum β-lactamase-producing Enterobacteriaceae in a university hospital, Clin Infect Dis, 29 (6):1411-1418, (1999).
25. Virk A, Steckelberg JM. Clinical aspects of antimicrobial resistance, Mayo Clin Proc, 75 (2): 200-214, (2000).
26. Frank M. Kaczmarek, Fadia DH, Wenchi S and Thomas DG, Antimicrob Agents and Chemother, 50 (10): 3396-3406, (2006).
27. Tenover FC, Rajinder KK, Williams PP, Carey RB, Sheila S and David L, Carbapenem Resistance in Klebsiella pneumoniae not detected by automated susceptibility testing, Emer Infect Dis, 12(8):1209-1213, (2006).
28. Chen LF, Klebsiella pneumoniae Carbapenemase: Extended-Spectrum beta-Lactamase Continues to Go Global, Medscape Infect Dis, Expert column, (2009).
29. Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B and McDougal LK, Evaluation of methods to identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae, J Clin Microbiol, 45 (8): 2723-2725, (2007).